FDA set to approve CRISPR gene editing to cure disease affecting 20M Black and Brown people worldwide
PLUS: OpenAI looks to hire a new CEO ... again. This time it's looking to hire a rival's CEO and merge the two companies.
Today’s Top Stories at the Intersection of Tech, Race, and Gender
👩🏽🔬🥼 Hope for Healing Sickle Cell Anemia: U.S. Federal Drug Administration (FDA) considers cutting edge treatment for disease that primarily affects Black people, sickle cell anemia. CRISPR gene editing for sickle cell anemia would be the first FDA approval for such a treatment option.
Keep reading with a 7-day free trial
Subscribe to DINT to keep reading this post and get 7 days of free access to the full post archives.